miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13081375
Abstract: Background: Hepatocellular carcinoma (HCC) is the second most common malignancy with increasing cancer deaths worldwide. HCC is mainly diagnosed at its advanced stage, and treatment with FDA-approved sorafenib, the multikinase inhibitor drug, is advised. Acquired… read more here.
Keywords: cell; autophagy glutamine; sorafenib resistant; sorafenib ... See more keywords